Non-invasive in-vivo prediction of therapeutic response to inhibitors of angiogenesis using gallium (68Ga) NODAGA-RGD PET/CT

ABSTRACT: Primary objectives: 1. To compare the response rate to treatment including antiangiogenic agent in patients with advanced metastatic cancer of the colon or rectum , according to whether or not all known lesions, were visually positive on gallium (68Ga) NODAGA-RGD PET/CT before starting treatment including antiangiogenic agent Primary endpoints: 1. Assessment of value of gallium (68Ga) NODAGA-RGD PET/CT to predict the response to treatment including antiangiogenic agent

DISEASE(S): Pokročilý Metastatický Karcinóm Hrubého Čreva Alebo Konečníka,Colon Cancer Metastatic,Colorectal Cancer Stage Iv,Advanced Metastatic Cancer Of The Colon Or Rectum,Colon Cancer Stage Iv,Colorectal Cancer Metastatic

PROVIDER: 2538006 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR